Desq Long
Sign in

Company

Krystal Biotech, Inc.

KRYS · CIK 0001711279

SEC FORM 4
$184,360.80

Krystal Biotech, Inc. (KRYS)

Sale of 520 shares at $354.54 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$208,195.20

Krystal Biotech, Inc. (KRYS)

Sale of 573 shares at $363.3424 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$494,963.03

Krystal Biotech, Inc. (KRYS)

Sale of 1,358 shares at $364.4794 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$309,507.61

Krystal Biotech, Inc. (KRYS)

Sale of 847 shares at $365.4163 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$148,455.46

Krystal Biotech, Inc. (KRYS)

Sale of 405 shares at $366.5567 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$721,455.39

Krystal Biotech, Inc. (KRYS)

Sale of 2,029 shares at $355.5719 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,174,947.60

Krystal Biotech, Inc. (KRYS)

Sale of 3,297 shares at $356.3687 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,423,501.30

Krystal Biotech, Inc. (KRYS)

Sale of 3,981 shares at $357.5738 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,126,508.40

Krystal Biotech, Inc. (KRYS)

Sale of 3,143 shares at $358.4182 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,206,459.14

Krystal Biotech, Inc. (KRYS)

Sale of 3,357 shares at $359.3861 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$816,809.16

Krystal Biotech, Inc. (KRYS)

Sale of 2,266 shares at $360.463 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$438,993.45

Krystal Biotech, Inc. (KRYS)

Sale of 1,214 shares at $361.6091 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$728,927.30

Krystal Biotech, Inc. (KRYS)

Sale of 2,010 shares at $362.6504 per share.

Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →

SEC FORM 4
$184,360.80

Krystal Biotech, Inc. (KRYS)

Sale of 520 shares at $354.54 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$205,287.33

Krystal Biotech, Inc. (KRYS)

Sale of 565 shares at $363.3404 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$484,390.07

Krystal Biotech, Inc. (KRYS)

Sale of 1,329 shares at $364.4771 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$301,831.88

Krystal Biotech, Inc. (KRYS)

Sale of 826 shares at $365.4139 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$146,255.84

Krystal Biotech, Inc. (KRYS)

Sale of 399 shares at $366.556 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$713,277.23

Krystal Biotech, Inc. (KRYS)

Sale of 2,006 shares at $355.5719 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,164,253.93

Krystal Biotech, Inc. (KRYS)

Sale of 3,267 shares at $356.3679 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,416,708.98

Krystal Biotech, Inc. (KRYS)

Sale of 3,962 shares at $357.5742 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,139,776.55

Krystal Biotech, Inc. (KRYS)

Sale of 3,180 shares at $358.4203 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,219,037.99

Krystal Biotech, Inc. (KRYS)

Sale of 3,392 shares at $359.3862 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$836,281.12

Krystal Biotech, Inc. (KRYS)

Sale of 2,320 shares at $360.466 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$449,119.62

Krystal Biotech, Inc. (KRYS)

Sale of 1,242 shares at $361.61 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$722,404.18

Krystal Biotech, Inc. (KRYS)

Sale of 1,992 shares at $362.6527 per share.

Reporting Person Krishnan Suma · Officer Title President, R&D · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001298711-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$111,029.09

Krystal Biotech, Inc. (KRYS)

Sale of 341 shares at $325.5985 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →

SEC FORM 4
$746,940.60

Krystal Biotech, Inc. (KRYS)

Sale of 2,287 shares at $326.6028 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,710,960.52

Krystal Biotech, Inc. (KRYS)

Sale of 5,226 shares at $327.3939 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →

SEC FORM 4
$554,205.14

Krystal Biotech, Inc. (KRYS)

Sale of 1,687 shares at $328.5152 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →

SEC FORM 4
$2,448,279.94

Krystal Biotech, Inc. (KRYS)

Sale of 7,428 shares at $329.6015 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,617,422.00

Krystal Biotech, Inc. (KRYS)

Sale of 4,896 shares at $330.3558 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,025,786.06

Krystal Biotech, Inc. (KRYS)

Sale of 3,095 shares at $331.4333 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →

SEC FORM 4
$13,329.20

Krystal Biotech, Inc. (KRYS)

Sale of 40 shares at $333.23 per share.

Reporting Person ROSSI DINO A · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001209059-26-000006 · filed 2026-08-14 · View filing →